Log in  First Connection?  Edition EN | FR

Archives   News of the month

 Japanese Encephalitis
Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies

Published on 03/03/2026 |  Original article (Abstract)  | Sarah A Boardman et al. | The Journal of infectious diseases. Volume 232(6). 1 min.

The blood-brain barrier (BBB) protects the brain from pathogenic microorganisms. Neurologic complications from viral infections, including herpes simplex virus, varicella zoster virus, HIV, Japanese encephalitis virus, and SARS-CoV-2, are linked to BBB dysfunction and loss of barrier integrity. Increased...

 Japanese Encephalitis
Modelling the risk of Japanese encephalitis virus in Victoria, Australia, using an expert-systems approach

Published on 26/08/2025 |  Original article (Abstract)  | Flores Lima Mariel et al. | BMC Infectious Diseases 2023; 24(1): 60 7 min.

Vector-borne diseases (VBDs) have been spreading geographically, which is largely attributed to climate change [1–4]. As new areas become suitable for vectors and pathogens, the threat to unexposed populations grows [5]. Japanese encephalitis virus (JEV) is a zoonotic disease transmitted by mosquitoes...

 Japanese Encephalitis
Mosquito vector competence for Japanese encephalitis virus: a systematic review and meta-analysis update

Published on 19/08/2025 |  Original article (Abstract)  | Edache Stephen et al. | Parasites & Vectors 2025; 18(1): 191 6 min.

Japanese encephalitis (JE) is an emerging zoonotic disease caused by the Japanese encephalitis virus (JEV), a flavivirus primarily transmitted by mosquitoes of the Culex genus. JE is a significant public health concern, causing around 100,000 cases and 25,000 deaths each year globally [1, 2]....

 Japanese Encephalitis
Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross‐sectional study

Published on 22/07/2025 |  Original article (Abstract)  | Madeleine J Marsland et al. | The Medical journal of Australia 2024; 220(11): 566-72 5 min.

The Victorian population was largely immunologically naïve to the Japanese encephalitis virus (JEV) before the 2022 outbreak. As most JEV infections are asymptomatic, their prevalence during the outbreak was unknown. The new: We found evidence of JEV infections across northern Victoria, including...

 Japanese Encephalitis
Trends in temporal and spatial changes of Japanese encephalitis in Chinese Mainland, 2004-2019: a population-based surveillance study

Published on 18/02/2025 |  Original article (Abstract)  | Fu, Yun-Qiang et al. | Travel medicine and infectious disease 2024; 60(July–August 2024): 102724 1 min.

Japanese encephalitis (JE) is a serious health concern in China, with approximately 80% of global infections occurring in China. To develop effective prevention and control strategies, this study explored the epidemiological characteristics of JE in China based on spatiotemporal data, to understand the...